Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Crooks

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Virology|June 21, 2007
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Emma T Crooks, Penny L Moore, Michael Franti, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Plos Pathogens|May 3, 2018
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturationEma T Crooks, Samantha L Grimley, Michelle Cully, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
ACS Omega|January 21, 2020
Development of a Novel Cell-Permeable Protein-Protein Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase 1David J Huggins, Bryn S Hardwick, Pooja Sharma, et al.
Ecohealth|February 27, 2016
Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and ResponseKathryn H Jacobsen, A Alonso Aguirre, Charles L Bailey, et al.
Cell Chemical Biology|June 10, 2021
Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide libraryAmy Emery, Bryn S Hardwick, Alex T Crooks, et al.
Journal of Virology|September 26, 2008
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and CJames M Binley, Elizabeth A Lybarger, Emma T Crooks, et al.
Journal of Virology|August 19, 2011
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsGeorgia D Tomaras, James M Binley, Elin S Gray, et al.
Plos Pathogens|May 30, 2015
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteEma T Crooks, Tommy Tong, Bimal Chakrabarti, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Virology|June 21, 2007
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Emma T Crooks, Penny L Moore, Michael Franti, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Plos Pathogens|May 3, 2018
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturationEma T Crooks, Samantha L Grimley, Michelle Cully, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
ACS Omega|January 21, 2020
Development of a Novel Cell-Permeable Protein-Protein Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase 1David J Huggins, Bryn S Hardwick, Pooja Sharma, et al.
Ecohealth|February 27, 2016
Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and ResponseKathryn H Jacobsen, A Alonso Aguirre, Charles L Bailey, et al.
Cell Chemical Biology|June 10, 2021
Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide libraryAmy Emery, Bryn S Hardwick, Alex T Crooks, et al.
Journal of Virology|September 26, 2008
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and CJames M Binley, Elizabeth A Lybarger, Emma T Crooks, et al.
Journal of Virology|August 19, 2011
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsGeorgia D Tomaras, James M Binley, Elin S Gray, et al.
Plos Pathogens|May 30, 2015
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteEma T Crooks, Tommy Tong, Bimal Chakrabarti, et al.
Pageof 5